To investigate this, we analyzed SDF-1 expression in MDS MSC cultures after treatment with recombinant GDF-8, GDF-15, and TGF-β in the presence or absence of RAP-536. This evidence concerns the gene TGFB1 and myelodysplastic syndrome.